10847460

Source:http://linkedlifedata.com/resource/pubmed/id/10847460

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:10847460	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:10847460	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:10847460	lifeskim:mentions	umls-concept:C0877373	lld:lifeskim
pubmed-article:10847460	lifeskim:mentions	umls-concept:C0246415	lld:lifeskim
pubmed-article:10847460	lifeskim:mentions	umls-concept:C0045093	lld:lifeskim
pubmed-article:10847460	lifeskim:mentions	umls-concept:C0920321	lld:lifeskim
pubmed-article:10847460	pubmed:issue	4	lld:pubmed
pubmed-article:10847460	pubmed:dateCreated	2000-10-6	lld:pubmed
pubmed-article:10847460	pubmed:abstractText	Docetaxel and gemcitabine are active in a broad range of malignancies. The objective of this phase I trial was to determine the maximally tolerated doses of the combination of docetaxel and gemcitabine.	lld:pubmed
pubmed-article:10847460	pubmed:language	eng	lld:pubmed
pubmed-article:10847460	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10847460	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:10847460	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10847460	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10847460	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10847460	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10847460	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10847460	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:10847460	pubmed:month	Apr	lld:pubmed
pubmed-article:10847460	pubmed:issn	0923-7534	lld:pubmed
pubmed-article:10847460	pubmed:author	pubmed-author:BoyerMM	lld:pubmed
pubmed-article:10847460	pubmed:author	pubmed-author:SmithJJ	lld:pubmed
pubmed-article:10847460	pubmed:author	pubmed-author:BishopJJ	lld:pubmed
pubmed-article:10847460	pubmed:author	pubmed-author:DavisonJJ	lld:pubmed
pubmed-article:10847460	pubmed:author	pubmed-author:ZalcbergJJ	lld:pubmed
pubmed-article:10847460	pubmed:author	pubmed-author:MichaelMM	lld:pubmed
pubmed-article:10847460	pubmed:author	pubmed-author:RischinDD	lld:pubmed
pubmed-article:10847460	pubmed:author	pubmed-author:MillwardMM	lld:pubmed
pubmed-article:10847460	pubmed:author	pubmed-author:McClureBB	lld:pubmed
pubmed-article:10847460	pubmed:author	pubmed-author:EmmettEE	lld:pubmed
pubmed-article:10847460	pubmed:issnType	Print	lld:pubmed
pubmed-article:10847460	pubmed:volume	11	lld:pubmed
pubmed-article:10847460	pubmed:owner	NLM	lld:pubmed
pubmed-article:10847460	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:10847460	pubmed:pagination	421-6	lld:pubmed
pubmed-article:10847460	pubmed:dateRevised	2006-11-15	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:meshHeading	pubmed-meshheading:10847460...	lld:pubmed
pubmed-article:10847460	pubmed:year	2000	lld:pubmed
pubmed-article:10847460	pubmed:articleTitle	A phase I trial of docetaxel and gemcitabine in patients with advanced cancer.	lld:pubmed
pubmed-article:10847460	pubmed:affiliation	Division of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Australia. drischin@petermac.unimelb.edu.au	lld:pubmed
pubmed-article:10847460	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:10847460	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:10847460	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:10847460	pubmed:publicationType	Clinical Trial, Phase I	lld:pubmed